8JXT image
Entry Detail
PDB ID:
8JXT
EMDB ID:
Title:
Histamine-bound H4R/Gi complex
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-07-01
Release Date:
2024-03-20
Method Details:
Experimental Method:
Resolution:
3.07 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Guanine nucleotide-binding protein G(i) subunit alpha-1
Mutations:G203A, A326S
Chain IDs:A (auth: B)
Chain Length:354
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
Chain IDs:B (auth: C)
Chain Length:345
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
Chain IDs:C (auth: D)
Chain Length:71
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:scFv16
Chain IDs:D (auth: E)
Chain Length:247
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Histamine H4 receptor
Chain IDs:E (auth: R)
Chain Length:390
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structural basis of ligand recognition and design of antihistamines targeting histamine H 4 receptor.
Nat Commun 15 2493 2493 (2024)
PMID: 38509098 DOI: 10.1038/s41467-024-46840-5

Abstact

The histamine H4 receptor (H4R) plays key role in immune cell function and is a highly valued target for treating allergic and inflammatory diseases. However, structural information of H4R remains elusive. Here, we report four cryo-EM structures of H4R/Gi complexes, with either histamine or synthetic agonists clobenpropit, VUF6884 and clozapine bound. Combined with mutagenesis, ligand binding and functional assays, the structural data reveal a distinct ligand binding mode where D943.32 and a π-π network determine the orientation of the positively charged group of ligands, while E1825.46, located at the opposite end of the ligand binding pocket, plays a key role in regulating receptor activity. The structural insight into H4R ligand binding allows us to identify mutants at E1825.46 for which the agonist clobenpropit acts as an inverse agonist and to correctly predict inverse agonism of a closely related analog with nanomolar potency. Together with the findings regarding receptor activation and Gi engagement, we establish a framework for understanding H4R signaling and provide a rational basis for designing novel antihistamines targeting H4R.

Legend

Protein

Chemical

Disease

Primary Citation of related structures